China Isotope & Radiation Corp
HKEX:1763
ROA
Return on Assets
ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.
ROA Across Competitors
| Country | Company | Market Cap | ROA | ||
|---|---|---|---|---|---|
| CN |
C
|
China Isotope & Radiation Corp
HKEX:1763
|
4.9B HKD |
3%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
34.8B CHF |
4%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
5.6T JPY |
17%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
144B DKK |
9%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13B USD |
7%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.9B GBP |
5%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.6B CHF |
7%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
47.5B CNY |
16%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.5B USD |
5%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD |
13%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.9T KRW |
-22%
|
China Isotope & Radiation Corp
Glance View
China Isotope & Radiation Corp. engages in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications. The company is headquartered in Beijing, Beijing. The company went IPO on 2018-07-06. The firm also provides radiation sterilization services. The firm is also involved in the design, manufacture and installation of Gama ray irradiation devices. The firm opeartes its businesse mainly through four segments, including the Pharmaceuticals segment, the Radiological Products segment, the Irradiation segment and the Independent Medical Laboratory Services and Others segment, with the Pharmaceuticals segment as the core segment. The Pharmaceuticals segment is engaged in the development, manufacture and sale of radiopharmaceuticals, the Kit for Urea Breath Test and testing instruments, as well as in vitro immunodiagnostic reagents and boxes for imaging diagnosis and treatment.
See Also
ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.
Based on China Isotope & Radiation Corp's most recent financial statements, the company has ROA of 2.9%.
You don't have any saved screeners yet